Olink Holding AB (publ) (OLK) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Diagnostics & Research industria. La empresa tiene su sede en Uppsala, Sweden. El CEO actual es Jon Heimer.
OLK tiene fecha de IPO 2021-03-26, 707 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $3.24B.
Olink Holding AB (publ) is a Swedish life sciences company founded in 2004 and headquartered in Uppsala that provides protein analysis products and services to academic institutions, government agencies, and biopharmaceutical and biotechnology companies. The company's platform includes Olink Explore for disease-specific research areas such as cardiovascular, metabolic, oncology, and neurology applications, along with customizable Olink Target and Olink Focus product lines. Olink offers comprehensive solutions spanning assay execution through its Olink Signature Q100 platform, analytical services including study design and data processing, and software tools such as NPX Manager and Olink Insight for data visualization and statistical analysis. The company operates a direct sales organization across the Americas, Europe, the Middle East, Africa, and Asia Pacific regions to serve its global customer base.
